Stryker Corporation
NYSE:SYK · New York Stock Exchange
+$9.29 today
Vol 2.23M · Avg 2.49M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-18.04%
Period High
$400.53
Period Low
$282.58
Latest
$307.80
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Amgen Inc.
NASDAQ:AMGN
$180.79B
Gilead Sciences, Inc.
NASDAQ:GILD
$152.44B
Pfizer Inc.
NYSE:PFE
$143.85B
Danaher Corporation
NYSE:DHR
$125.53B
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
$114.86B
Sanofi
NASDAQ:SNY
$101.47B
Medtronic plc
NYSE:MDT
$101.25B
McKesson Corporation
NYSE:MCK
$88.03B
HCA Healthcare, Inc.
NYSE:HCA
$83.35B
Boston Scientific Corporation
NYSE:BSX
$67.35B
What is the latest SYK filing?
The latest filing shown is 4 dated Jun 2, 2026.
How many recent filings does SYK have?
Intrinsic Alpha currently shows 20 recent filings for SYK.
Explore More
Continue the stock analysis
Jump to another research area for this company.